Mutations activating the function of ras proto-oncogenes are often observed
in human tumors. Their oncogenic potential is mainly due to permanent stim
ulation of cellular proliferation and dramatic changes in morphogenic react
ions of the cell. To learn more on the role of ras activation in cancerogen
esis we studied its effects on chromosome stability and cell cycle checkpoi
nts. Since the ability of ras oncogenes to cause cell transformation may be
dependent on activity of the p53 tumor-suppressor the cells with different
p53 state were analysed. Ectopic expression of N-ras(asp12) caused in p53-
deficient MDAH041 cell line an augmentation in the number of chromosome bre
aks in mitogenic cells, significant increase in the frequency of metaphases
showing chromosome endoreduplication and accumulation of polyploid cells.
Similar effects were induced by different exogenous ras genes (N-ras(asp12)
, H-ras(leu12), N-ras proto-oncogene) in Rat1 and Rat2 cells which have a d
efect in p53-upstream pathways. In contrast, in REF52 and human LIM1215 cel
ls showing ras-induced p53 upregulation, ras expression caused only slight
increase in the number of chromosome breaks and did not enhance the frequen
cy of endoreduplication and polyploidy. Inactivation in these cells of p53
function by transduction of dominant-negative C-terminal p53 fragment (gene
tic suppressor element #22, GSE22) or mutant p53s significantly increased t
he frequency of both spontaneous and uas-induced karyotypic changes. In con
cordance with these observations we have found that expression of uns oncog
ene caused in p53-defective cells further mitigation of ethyl-metansulphona
te-induced G1 and G2 cell cycle arrest, but did not abrogate G1 and G2 cell
cycle checkpoints in cells with normal p53 function. These data indicate t
hat along with stimulation of cell proliferation and morphological transfor
mation uas activation can contribute to cancerogenesis by increasing geneti
c instability.